LONDON--(BUSINESS WIRE)--At the 9th International Conference in Genomics and Proteomics of Human Pathogens in London, UK, Bruker Daltonics Inc. and Isis Pharmaceuticals, Inc. today announced the European introduction of the Ibis T5000(TM) biosensor system for the identification and characterization of microorganisms. The Ibis T5000 system is an automated biosensor for healthcare research applications, which enables the analysis of viruses, bacteria, and fungi without any microbial culturing or genome sequencing steps. The Ibis T5000 relies on technology and applications developed by Ibis Biosciences(TM), a division of Isis Pharmaceuticals, incorporating Bruker Daltonics’ proven micrOTOF(TM) ESI TOF mass spectrometer.
